Antihypertensive Properties of Lactoferricin B-Derived Peptides
- 6 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 58 (11) , 6721-6727
Abstract
A set of eight lactoferricin B (LfcinB)-derived peptides was examined for inhibitory effects on angiotensin I-converting enzyme (ACE) activity and ACE-dependent vasoconstriction, and their hypotensive effect in spontaneously hypertensive rats (SHR). Peptides were derived from different elongations both at the C-terminal and N-terminal ends of the representative peptide LfcinB20−25, which is known as the LfcinB antimicrobial core. All of the eight LfcinB-derived peptides showed in vitro inhibitory effects on ACE activity with different IC50 values. Moreover, seven of them showed ex vivo inhibitory effects on ACE-dependent vasoconstriction. No clear correlation between in vitro and ex vivo inhibitory effects was found. Only LfcinB20−25 and one of its fragments, F1, generated after a simulated gastrointestinal digestion, showed significant antihypertensive effects in SHR after oral administration. Remarkably, F1 did not show any effect on ACE-dependent vasoconstriction in contrast to the inhibitory effect showed by LfcinB20−25. In conclusion, two LfcinB-derived peptides lower blood pressure and exhibit potential as orally effective antihypertensive compounds, yet a complete elucidation of the mechanism(s) involved deserves further ongoing research.Keywords
This publication has 37 references indexed in Scilit:
- Modeling of the Relationship between Dipeptide Structure and Dipeptide Stability, Permeability, and ACE Inhibitory ActivityJournal of Food Science, 2009
- The antihypertensive effect of peptides: A novel alternative to drugs?Peptides, 2008
- Antihypertensive and antimicrobial bioactive peptides from milk proteinsEuropean Food Research and Technology, 2007
- Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and ProductionCurrent Pharmaceutical Design, 2007
- Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activityInternational Dairy Journal, 2006
- Structural Requirements of Angiotensin I‐Converting Enzyme Inhibitory Peptides: Quantitative Structure‐Activity Relationship Modeling of Peptides Containing 4‐10 Amino Acid ResiduesQSAR & Combinatorial Science, 2006
- Structural Requirements of Angiotensin I-Converting Enzyme Inhibitory Peptides: Quantitative Structure−Activity Relationship Study of Di- and TripeptidesJournal of Agricultural and Food Chemistry, 2006
- Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteinsEuropean Food Research and Technology, 2004
- Bioavailability of angiotensin I converting enzyme inhibitory peptidesBritish Journal of Nutrition, 2004
- The renin–angiotensin and the kallikrein–kinin systemsThe International Journal of Biochemistry & Cell Biology, 2003